Validation in a multiple urology practice cohort of the Prostate Cancer Prevention Trial calculator for predicting prostate cancer detection.
about
Averaged differential expression for the discovery of biomarkers in the blood of patients with prostate cancerCan urinary PCA3 supplement PSA in the early detection of prostate cancer?Prediction models in cancer care.Identification of functionally active, low frequency copy number variants at 15q21.3 and 12q21.31 associated with prostate cancer risk.Improving patient prostate cancer risk assessment: Moving from static, globally-applied to dynamic, practice-specific risk calculators.Prostate cancer risk prediction in a urology clinic in Mexico.The risk of biopsy-detectable prostate cancer using the prostate cancer prevention Trial Risk Calculator in a community settingA simple decision analytic solution to the comparison of two binary diagnostic tests.Evaluating the PCPT risk calculator in ten international biopsy cohorts: results from the Prostate Biopsy Collaborative Group.The impact of prostate volume, number of biopsy cores and American Urological Association symptom score on the sensitivity of cancer detection using the Prostate Cancer Prevention Trial risk calculator.Updating risk prediction tools: a case study in prostate cancer.External validation of the Prostate Cancer Prevention Trial and the European Randomized Study of Screening for Prostate Cancer risk calculators in a Chinese cohort.The Prostate Cancer Prevention Trial risk calculator and the relationship between prostate-specific antigen and biopsy outcome.Prospective evaluation of operating characteristics of prostate cancer detection biomarkers.Incorporation of detailed family history from the Swedish Family Cancer Database into the PCPT risk calculatorThe Huashan risk calculators performed better in prediction of prostate cancer in Chinese population: a training study followed by a validation study.Risk-based prostate cancer screening.Risk-based prostate cancer screening: who and how?Do prostate cancer risk models improve the predictive accuracy of PSA screening? A meta-analysis.The prostate cancer prevention trial risk calculator 2.0 performs equally for standard biopsy and MRI/US fusion-guided biopsy.A nomogram for prediction of prostate cancer on multi-core biopsy using age, serum prostate-specific antigen, prostate volume and digital rectal examination in Singapore.The prostate cancer risk calculator from the Prostate Cancer Prevention Trial underestimates the risk of high grade cancer in contemporary referral patients.The use of the finasteride-adjusted Prostate Cancer Prevention Trial Prostate Cancer Risk Calculator in a Mexican referral population: a validation study.Can Western based online prostate cancer risk calculators be used to predict prostate cancer after prostate biopsy for the Korean population?Multiparametric magnetic resonance imaging outperforms the Prostate Cancer Prevention Trial risk calculator in predicting clinically significant prostate cancer.
P2860
Q27304922-E3F5155F-17A8-433D-BE73-BA274B81A0E2Q34692263-1661E138-C75D-4A6F-BFDB-5DBB3EDBD809Q35292878-D6CB1EEB-8583-452B-BC23-7CF923262963Q35921826-3B8C132F-1AAC-458E-B8D9-7D795511BBC9Q35940811-B63042F8-F744-450B-8F44-8B9AEB0FCEBDQ35996067-1DAA36AA-34CD-4AE0-854E-AE3944F55D86Q36185925-2BD6F487-5636-43E9-9D80-622AB4FEF294Q36492300-A07380E2-02A1-4BBD-A9FA-3413937FBFD6Q36739758-DA24876A-83B9-4147-A9FB-7B83615E846BQ37001612-A3C77248-ED56-492C-8BB9-63F51CFEB7FAQ37025404-7E36CABC-DDA2-4B2A-80F7-64BFBD03380BQ37074118-3026841C-6172-4DE4-8BA2-2FB93A2395C1Q37075718-A72BFBD9-B890-4115-BF52-148989D6E36CQ37252155-99C5FC5F-506F-4C1D-B276-ADB83C831895Q37279076-79A9FBDA-B4E5-4D29-A861-78EBF6E7CDC1Q37414994-6514F55D-F8AB-4A46-9251-CB43567C0869Q37963657-A3D646F4-CB93-4511-A7F9-C65E05D45A1FQ38093463-36FF33E3-9DD0-443C-BDD5-A18F0FEC62B0Q38268839-59C9F8B1-D0EE-43BE-9E95-BA975C8B50BFQ38950693-4C02D929-CA80-4CAF-A2A2-8DE4E65CF277Q39377009-57A70397-161F-4388-9F2F-D5F1052334E7Q39963357-5795A24D-7698-4C91-8408-9EBC6F7BDFC9Q40037072-7F000619-EF8A-4318-9A91-66B4A0400B6DQ40087634-A3078432-83C7-4970-A47E-9C111159C26FQ40199490-08FC7C5E-21A0-4718-86DA-069026BC982A
P2860
Validation in a multiple urology practice cohort of the Prostate Cancer Prevention Trial calculator for predicting prostate cancer detection.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Validation in a multiple urolo ...... ing prostate cancer detection.
@en
Validation in a multiple urolo ...... ing prostate cancer detection.
@nl
type
label
Validation in a multiple urolo ...... ing prostate cancer detection.
@en
Validation in a multiple urolo ...... ing prostate cancer detection.
@nl
prefLabel
Validation in a multiple urolo ...... ing prostate cancer detection.
@en
Validation in a multiple urolo ...... ing prostate cancer detection.
@nl
P2093
P2860
P1476
Validation in a multiple urolo ...... ing prostate cancer detection.
@en
P2093
Gerrardina Bueti
Ian M Thompson
Jeffrey Tang
John T Wei
Martin G Sanda
Meredith M Regan
Michael Kearney
Prakash V Nair
Stephen J Eyre
P2860
P304
P356
10.1016/J.JURO.2009.08.056
P407
P577
2009-12-01T00:00:00Z